早期XIII因子替代在分娩后死亡的效果:多中心,开放标签,随机,受控,研究者发起的试验的研究协议
Christian Haslinger1,2, Torsten Hothorn3, Verena Bossung4
1Department of Obstetrics, University Hospital Zurich, Zürich, ZH, Switzerland christian.haslinger@usz.ch.
BMJ open
|May 9, 2025
概括
这项研究调查了补充凝血因子XIII (FXIII) 是否可以减少产后出血 (PPH) 的妇女的血液损失. 假设FXIII的使用可显著降低PPH患者的测量血液损失 (MBL).
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 临床试验 临床试验
背景情况:
- 产后出血 (PPH) 仍然是孕产妇发病率和死亡率的重要原因.
- 凝血因子XIII (FXIII) 在稳定血栓方面发挥着至关重要的作用.
- 以前的研究表明,FXIII补充可能会减轻过度出血.
研究的目的:
- 评估FXIII在减少PPH的女性测量血液损失 (MBL) 的疗效.
- 为了测试假设,FXIII补充显著降低产后血流.
主要方法:
- 这是一项随机对照试验,涉及988名符合条件的患者,在接受过胺酸后被诊断患有PPH.
- 患者被分配到接受FXIII或标准护理.
- 主要终点是24小时内MBL,使用连续结果逻辑回归分析.
主要成果:
- 主要分析将根据比例赔率假设估计减少MBL的赔率比率.
- 二次结果包括不良的母亲结果,母乳养率和FXIII安全性.
- 此外,还包括对凝血因子动态和成本效益的探索.
结论:
- 这项研究旨在提供证据,证明FXIII在管理PPH方面的有效性.
- 这些发现将为临床实践提供有关FXIII用于减少产后出血的信息.
- 结果将通过开放访问出版物进行传播.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
Clot Retraction and Fibrinolysis
3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K
Disorders of Hemostasis
658
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
658
Coagulation
3.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.7K
Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K


